Foundation News

Stay up-to-date with the most current news and information about the Crohn's & Colitis Foundation, as well as Crohn's disease and ulcerative colitis.

Sunshine may decrease risk of inflammatory bowel disease

A new study published by Australian National University found that exposure to sunlight for only half an hour a day could decrease a child’s risk of experiencing IBD related symptoms.

July 31, 2019

New Research Reveals High Cost of Care for Inflammatory Bowel Disease Patients in the United States

NEW YORK, NY – The cost of care for inflammatory bowel disease (IBD) in the United States has increased significantly over the past five years, according to the results of the Crohn’s & Colitis Foundation’s cost of care study.

May 21, 2019

Crohn's & Colitis Foundation Unveils New Five-Year Research Agenda

NEW YORK, NY – Today, the Crohn’s & Colitis Foundation released its new five-year research agenda to address unmet needs in the inflammatory bowel disease (IBD) research community and provide a roadmap for not only the Foundation but also the IBD research community at-large.

May 16, 2019

May Tennessee News

Ever wanted to own a pair of NFL cleats? Well now you can! Jordan Wilkins of the Indianapolis Colts has generously donated a pair of cleats and a helmet that he's autographed. Click here to bid on them today!

May 10, 2019

Wisconsin Chapter April Update

We hope you're excited for all the upcoming events we're planning in Wisconsin this year!

April 22, 2019

Leading Gastroenterology Organizations Announce Funding to Improve Vaccine Utilization and Preventive Health Maintenance

New York, New York – The American College of Gastroenterology (ACG), the American Gastroenterological Association (AGA), and the Crohn’s & Colitis Foundation (Foundation), in partnership with Pfizer, Inc., have announced the results of a request for proposal (RFP) to address vaccine utilizati

March 8, 2019

Crohn’s & Colitis Foundation Launches New Online Journal

New York, New York – The Crohn’s & Colitis Foundation is launching a new open access journal to engage, inform, and catalyze dialogue on state-of-the-art, comprehensive care for the millions ofAmericans living with inflammatory bowel diseases (IBD).

January 24, 2019

Predictimmune and the Crohn’s & Colitis Foundation Announce a Joint Study to Validate and Prove Efficacy of First Prognostic Test for IBD in the US Market

CAMBRIDGE, England—PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today announced details of a jointly sponsored study with the US Crohn’s & Colitis Foundation.

December 4, 2018